Stock Comparison

ABT vs BSX

Abbott Laboratories and Boston Scientific Corp side by side — valuation, profitability, growth and risk.

ABT

Abbott Laboratories

Healthcare

BSX

Boston Scientific Corp

Healthcare

Valuation

Market Cap

$163.94B

$65.74B

P/E (TTM)

26.4

18.5

Forward P/E

17.2

13.2

Price/Sales

3.6

3.2

Price/Book

3.2

2.5

EV/EBITDA

16.1

13.7

Dividend Yield

2.62%

—

Profitability

Net Margin

13.90%

17.30%

Operating Margin

13.50%

20.60%

Return on Equity

12.30%

14.70%

Return on Assets

5.59%

6.07%

Growth (YoY)

Revenue Growth

7.80%

11.60%

Earnings Growth

-19.70%

100.00%

Price & Risk

Beta

0.6

52-Week High

$135.34

$109.50

52-Week Low

$81.97

$43.89

Analyst Target

$116.54

$75.00

Compare ABT and BSX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.